Listen to the article
A little over a year ago, Pfizer changed its corporate identity and today Pharma giant Sanofi is doing the same.
The French Big Pharma has unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in December 2019.
The new logo-- Sanofi in black, lower-case letters, bookended with two purple dots -- aims to represent Sanofi’s new purpose and ambition, which is inspired by the simple and motion-oriented codes of the tech industry.
The two purple dots embody the scientific journey between a starting point – the curiosity of questioning the status-quo and wondering “what if?” – and a finish line – the eureka moment where innovative solutions are unlocked to impact people’s lives.
“With our new brand, we have sought to provide our people, our partners, patients and healthcare professionals with a clear and strong understanding of who we are and what we are set to achieve,” said Josep Catllà, Head of Corporate Affairs at Sanofi. “Sanofi’s attitude is humble, authentic—and a little bit unconventionl too. We believe that our new brand and logo carve out a unique space in the healthcare industry that perfectly represents our new purpose to chase the miracles of science to improve people’s lives.”
With roots in a variety of diverse companies, Sanofi is today the combination of many cultures, identities, and brands. Its new brand is rooted in this heritage and brings this diverse history together in single common identity for the first time. This manifestation of the company’s journey highlights an ambitious strategy for the future.
Sanofi Chief Executive Officer Paul Hudson called this the “most important transformation and modernization” in the company’s five-decade history. “In 2019, we launched our Play to Win strategy, which focuses on applying our platform for innovation to produce first- and best-in-class treatments and vaccines. Our new brand is a natural and important next step in this journey and represents the integrated way in which the company will work to achieve our shared ambition to transform the practice of medicine.”
Current business units Sanofi Pasteur and Sanofi Genzyme, focused on vaccines and specialty care respectively, and all other acquired brands, will be united under the singular Sanofi name and brand. These brands have for years symbolized the impact that innovation can have on people’s lives. Thinking, acting, and behaving as a single entity under a new shared purpose and identity will position Sanofi to have greater impact by more strategically applying the resources that exist across the company to drive innovations that matter.
